Skip to main content
Top
Published in: Supportive Care in Cancer 8/2016

01-08-2016 | Original Article

Prediction of skeletal-related events in patients with non-small cell lung cancer

Authors: Hisaki Aiba, Tomoki Kimura, Takaya Yamagami, Nobuyuki Watanabe, Hironari Sakurai, Hiroaki Kimura, Shingo Shimozaki, Satoshi Yamada, Takanobu Otsuka

Published in: Supportive Care in Cancer | Issue 8/2016

Login to get access

Abstract

Purpose

Advanced lung cancer frequently causes bone metastasis which can be associated with skeletal-related events (SREs) that may cause significant deterioration of the patient’s quality of life (QoL). The Spinal Instability Neoplastic Score (SINS) can be used to assist in standardizing evaluations of neoplastic spinal instability between spinal and non-spine surgeons. This research investigated the association between SREs and SINS for patients with non-small cell lung cancer (NSCLC).

Methods

Between 2009 and 2013, 47 patients with NSCLC who were diagnosed with bone metastasis were classified using SINS into either a stable group (SINS, 0–6 points) or unstable group (SINS, 7–18 points). The primary endpoint was time from diagnosis of metastasis to SREs. Secondary endpoints included tumor type and epidermal growth factor receptor (EGFR) mutational status. SREs were defined as spinal compression, pathologic fracture, spinal surgery, and hypercalcemia.

Results

Patients included 37 cases of adenocarcinoma and 10 cases of squamous cell carcinoma. Mean follow-up time was 10.2 ± 13.7 months. SRE incidence was 15.0 % (3/20) in the stable group versus 44.4 % (12/27) in the unstable group (p = 0.048). A Cox regression model revealed that an EGFR-positive mutational status (hazard ratio [HR] = 0.15, 95 % CI, 0.030.71; p = 0.017) or good spinal stability (HR = 0.49; 0.08–0.99; p = 0.049) were favorable prognostic factors.

Conclusion

The incidence of SREs was significantly lower in NSCLC patients with better spinal stability as determined by SINS, which was a good prediction tool for SREs from bone metastasis. The lower incidence of SREs in EGFR-positive patients suggests tumor biology should be considered when predicting SREs.
Literature
3.
go back to reference Huisman M, van der Velden JM, van Vulpen M, van den Bosch MA, Chow E, Öner FC, Yee A, Verkooijen HM, Verlaan JJ (2014) Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J 14(12):2835–2840. doi:10.1016/j.spinee.2014.03.043 CrossRefPubMed Huisman M, van der Velden JM, van Vulpen M, van den Bosch MA, Chow E, Öner FC, Yee A, Verkooijen HM, Verlaan JJ (2014) Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J 14(12):2835–2840. doi:10.​1016/​j.​spinee.​2014.​03.​043 CrossRefPubMed
4.
go back to reference Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, Bilsky MH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fisher CG (2011) Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29(22):3072–3077. doi:10.1200/JCO.2010.34.3897 CrossRefPubMed Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, Bilsky MH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fisher CG (2011) Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 29(22):3072–3077. doi:10.​1200/​JCO.​2010.​34.​3897 CrossRefPubMed
5.
go back to reference Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, Kawahara N, Fourney D, Weir L, Reynolds JJ, Sahgal A, Fehlings MG, Gokaslan ZL (2014) Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol 9:69. doi:10.1186/1748-717X-9-69 CrossRefPubMedPubMedCentral Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, Kawahara N, Fourney D, Weir L, Reynolds JJ, Sahgal A, Fehlings MG, Gokaslan ZL (2014) Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol 9:69. doi:10.​1186/​1748-717X-9-69 CrossRefPubMedPubMedCentral
6.
go back to reference Hirsh V, Major PP, Lipton A, Cook RJ, Langer CJ, Smith MR, Brown JE, Coleman RE (2008) Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. J Thorac Oncol 3(3):228–236. doi:10.1097/JTO.0b013e3181651c0e CrossRefPubMed Hirsh V, Major PP, Lipton A, Cook RJ, Langer CJ, Smith MR, Brown JE, Coleman RE (2008) Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity. J Thorac Oncol 3(3):228–236. doi:10.​1097/​JTO.​0b013e3181651c0e​ CrossRefPubMed
8.
go back to reference Simoff MJ, Lally B, Slade MG, Goldberg WG, Lee P, Michaud GC, Wahidi MM, Chawla M, Chest (2013) Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e455S–e497S. doi:10.1378/chest.12-2366 CrossRefPubMed Simoff MJ, Lally B, Slade MG, Goldberg WG, Lee P, Michaud GC, Wahidi MM, Chawla M, Chest (2013) Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e455S–e497S. doi:10.​1378/​chest.​12-2366 CrossRefPubMed
9.
go back to reference Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamura T (2001) Surgical strategy for spinal metastasis. Spine (Phila Pa 1976) 26(3):298–306CrossRef Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamura T (2001) Surgical strategy for spinal metastasis. Spine (Phila Pa 1976) 26(3):298–306CrossRef
11.
go back to reference Weigel B, Maghsudi M, Neumann C, Kretschmer R, Müller FJ, Nerlich M (1999) Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine (Phila Pa 1976) 24(21):2240–2246CrossRef Weigel B, Maghsudi M, Neumann C, Kretschmer R, Müller FJ, Nerlich M (1999) Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine (Phila Pa 1976) 24(21):2240–2246CrossRef
15.
16.
go back to reference Teixeira WG, Coutinho PR, Marchese LD, Narazaki DK, Cristante AF, Teixeira MJ, Barros Filho TE, Camargo OP (2013) Interobserver agreement for the spine instability neoplastic score varies according to the experience of the evaluator. Clinics (Sao Paulo) 68(2):213–218. doi:10.6061/clinics/2013(02)OA15 CrossRef Teixeira WG, Coutinho PR, Marchese LD, Narazaki DK, Cristante AF, Teixeira MJ, Barros Filho TE, Camargo OP (2013) Interobserver agreement for the spine instability neoplastic score varies according to the experience of the evaluator. Clinics (Sao Paulo) 68(2):213–218. doi:10.​6061/​clinics/​2013(02)OA15 CrossRef
Metadata
Title
Prediction of skeletal-related events in patients with non-small cell lung cancer
Authors
Hisaki Aiba
Tomoki Kimura
Takaya Yamagami
Nobuyuki Watanabe
Hironari Sakurai
Hiroaki Kimura
Shingo Shimozaki
Satoshi Yamada
Takanobu Otsuka
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3167-5

Other articles of this Issue 8/2016

Supportive Care in Cancer 8/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine